Stay updated on Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a page version metadata update.
    Difference
    0.1%
    Check dated 2026-06-05T08:37:12.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, indicating a newer document revision. This reflects a metadata update to the page rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-05-14T22:36:19.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.3, replacing v3.5.2, indicating a minor page revision. This is a metadata-level update rather than a substantive change to the page content.
    Difference
    0.1%
    Check dated 2026-04-30T15:39:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:43.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:49:40.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 to reflect the latest build.
    Difference
    0.1%
    Check dated 2026-03-11T16:55:18.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.